COVID-19

Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108

PALI-2108 is orally delivered and colon-specific allowing for local activity with low systemic exposure Company on track to commence Phase…

2 years ago

Medical Virtual Assistant Market Size to Grow USD 2668.4 Million by 2029 at a CAGR of 27.9% | Valuates Reports

BANGALORE, India, June 10, 2024 /PRNewswire/ -- Medical Virtual Assistant Market is Segmented by Type (Virtual Health Coaches, Virtual Health…

2 years ago

Drug Discovery Informatics Market Size to Grow USD 1 Million by 2030 at a CAGR of 9% | Valuates Reports

BANGALORE, India, June 10, 2024 /PRNewswire/ -- Drug Discovery Informatics Market is Segmented by Type (Software, Services), by Application (Pharmaceutical & Biotechnology Companies,…

2 years ago

Cell & Gene Therapy Supply Chain Software Market Expected to Grow at a 13.9% CAGR from 2024-2031 | Latest Report by InsightAce Analytic

JERSEY CITY, N.J., June 10, 2024 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report…

2 years ago

FSi Partners with Microsoft and the White House to Support Rural Healthcare Cybersecurity

VIENNA, Va., June 10, 2024 /PRNewswire/ -- FSi Strategies, a leading Microsoft managed IT service provider, announced today that it…

2 years ago

IQAir Introduces New XE Smart Air Purifiers

STEINACH, Switzerland, June 10, 2024 /PRNewswire/ -- IQAir, a Swiss air quality technology company, launches their new XE air purifiers,…

2 years ago

Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19

mRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines…

2 years ago

AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference

Live video webcast on Monday, June 17th at 1:00 PM ETOCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech…

2 years ago

Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 10, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the…

2 years ago

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

Manufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending…

2 years ago